Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study. (Q35252908)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study. |
scientific article |
Statements
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study (English)
Howard I Scher
Celestia S Higano
Nicholas J Vogelzang
Matthew R Smith
Christopher J Sweeney
Paul G Corn
David C Smith
Maha Hussain
Daniel J George
Andrea L Harzstark
A Oliver Sartor
Michael S Gordon
Johann S de Bono
Naomi B Haas
Christopher J Logothetis
Aymen Elfiky
Christian Scheffold
A Douglas Laird
Frauke Schimmoller
Ethan M Basch
15 September 2014